Published in BMJ on March 03, 2008
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ (2010) 5.68
The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ (2010) 5.58
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ (2012) 5.57
Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ (2009) 4.48
Obstetric outcomes after treatment of periodontal disease during pregnancy: systematic review and meta-analysis. BMJ (2010) 4.44
Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ (2009) 4.38
Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis. BMJ (2011) 3.69
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ (2010) 2.88
Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making (2013) 2.43
Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol (2009) 2.39
A review of online evidence-based practice point-of-care information summary providers. J Med Internet Res (2010) 2.31
The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ (2009) 2.29
Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med (2013) 2.25
A pragmatic view on pragmatic trials. Dialogues Clin Neurosci (2011) 2.19
Selenium for preventing cancer. Cochrane Database Syst Rev (2011) 2.11
Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins. BMJ (2014) 2.09
The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study. PLoS One (2011) 2.02
Identifying items to assess methodological quality in physical therapy trials: a factor analysis. Phys Ther (2014) 1.99
Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol (2011) 1.97
The effect of India's total sanitation campaign on defecation behaviors and child health in rural Madhya Pradesh: a cluster randomized controlled trial. PLoS Med (2014) 1.94
Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med (2013) 1.92
A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children. PLoS Med (2011) 1.90
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ (2011) 1.86
Causal inference methods to study nonrandomized, preexisting development interventions. Proc Natl Acad Sci U S A (2010) 1.86
The health impacts of housing improvement: a systematic review of intervention studies from 1887 to 2007. Am J Public Health (2009) 1.79
Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol (2012) 1.76
Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ (2009) 1.73
Avoidable waste of research related to inadequate methods in clinical trials. BMJ (2015) 1.65
The effectiveness of the McKenzie method in addition to first-line care for acute low back pain: a randomized controlled trial. BMC Med (2010) 1.58
Use of placebo controls in the evaluation of surgery: systematic review. BMJ (2014) 1.57
Statistical and methodological considerations for reporting RCTs in medical literature. Korean J Anesthesiol (2015) 1.48
An assessment of the methodological quality of published network meta-analyses: a systematic review. PLoS One (2015) 1.47
The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis. Osteoporos Int (2015) 1.47
Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol (2009) 1.46
Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial. BMJ (2012) 1.45
Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Crit Care (2013) 1.43
Randomised trial support for orthopaedic surgical procedures. PLoS One (2014) 1.42
Causal assessment of dietary acid load and bone disease: a systematic review & meta-analysis applying Hill's epidemiologic criteria for causality. Nutr J (2011) 1.41
Efficacy and degree of bias in knee injury prevention studies: a systematic review of RCTs. Clin Orthop Relat Res (2012) 1.40
Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev (2009) 1.39
Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone. Addiction (2013) 1.39
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev (2014) 1.36
The enhanced recovery after surgery (ERAS) pathway for patients undergoing colorectal surgery: an update of meta-analysis of randomized controlled trials. Int J Colorectal Dis (2012) 1.35
Influence of initial severity of depression on effectiveness of low intensity interventions: meta-analysis of individual patient data. BMJ (2013) 1.33
Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols. J Clin Epidemiol (2012) 1.32
Issues in noninferiority trials: the evidence in community-acquired pneumonia. Clin Infect Dis (2008) 1.32
Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis (2011) 1.31
Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ (2012) 1.28
The value of educational messages embedded in a community-based approach to combat dengue Fever: a systematic review and meta regression analysis. PLoS Negl Trop Dis (2011) 1.28
New treatments compared to established treatments in randomized trials. Cochrane Database Syst Rev (2012) 1.28
Evidence from the Cochrane Collaboration for Traditional Chinese Medicine therapies. J Altern Complement Med (2009) 1.27
Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2012) 1.26
Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ (2013) 1.22
Case management used to optimize cancer care pathways: a systematic review. BMC Health Serv Res (2008) 1.21
Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ (2013) 1.21
Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev (2009) 1.17
Developing a guideline for clinical trial protocol content: Delphi consensus survey. Trials (2012) 1.17
Methodological quality of meta-analyses on treatments for chronic obstructive pulmonary disease: a cross-sectional study using the AMSTAR (Assessing the Methodological Quality of Systematic Reviews) tool. NPJ Prim Care Respir Med (2015) 1.17
Selenium for preventing cancer. Cochrane Database Syst Rev (2014) 1.17
Interventions to improve water quality for preventing diarrhoea. Cochrane Database Syst Rev (2015) 1.16
Evidence synthesis for decision making 7: a reviewer's checklist. Med Decis Making (2013) 1.16
Evidence at a glance: error matrix approach for overviewing available evidence. BMC Med Res Methodol (2010) 1.16
Guidelines for randomized clinical trial protocol content: a systematic review. Syst Rev (2012) 1.15
Sample size determinations in original research protocols for randomised clinical trials submitted to UK research ethics committees: review. BMJ (2013) 1.15
Meta-analysis in medical research. Hippokratia (2010) 1.14
The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute? J R Soc Med (2009) 1.14
Upgrading a Piped Water Supply from Intermittent to Continuous Delivery and Association with Waterborne Illness: A Matched Cohort Study in Urban India. PLoS Med (2015) 1.14
Effects of different impact exercise modalities on bone mineral density in premenopausal women: a meta-analysis. J Bone Miner Metab (2009) 1.12
The Primary Care Research Object Model (PCROM): a computable information model for practice-based primary care research. J Am Med Inform Assoc (2008) 1.12
The use of follicle flushing during oocyte retrieval in assisted reproductive technologies: a systematic review and meta-analysis. Hum Reprod (2012) 1.08
Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons. BMC Med Res Methodol (2012) 1.06
Evidence-based mechanistic reasoning. J R Soc Med (2010) 1.06
Rethinking clinical trials of transcranial direct current stimulation: participant and assessor blinding is inadequate at intensities of 2mA. PLoS One (2012) 1.06
Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2012) 1.05
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial. BMJ (2015) 1.05
Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review. HPB (Oxford) (2010) 1.04
Exposing the evidence gap for complementary and alternative medicine to be integrated into science-based medicine. J R Soc Med (2011) 1.03
Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev (2015) 1.03
Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev (2012) 1.03
Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PLoS One (2013) 1.03
Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses. J Cancer Res Clin Oncol (2014) 1.02
Weight-for-age z-score as a proxy marker for diarrhoea in epidemiological studies. J Epidemiol Community Health (2009) 1.02
Assessing water filtration and safe storage in households with young children of HIV-positive mothers: a randomized, controlled trial in Zambia. PLoS One (2012) 1.02
Reporting the level of evidence in the Canadian Journal of Plastic Surgery: Why is it important? Can J Plast Surg (2012) 1.01
The impact of school water, sanitation, and hygiene interventions on the health of younger siblings of pupils: a cluster-randomized trial in Kenya. Am J Public Health (2013) 1.01
Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update (2010) 1.01
Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol (2014) 1.00
Sodium dichloroisocyanurate tablets for routine treatment of household drinking water in periurban Ghana: a randomized controlled trial. Am J Trop Med Hyg (2010) 1.00
The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration. Syst Rev (2013) 1.00
Exercise effects on bone mineral density in older adults: a meta-analysis of randomized controlled trials. Age (Dordr) (2011) 0.99
Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis. Arthritis Rheum (2012) 0.99
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet (1998) 19.31
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med (2001) 8.17
Bias in clinical intervention research. Am J Epidemiol (2006) 7.09
Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA (2002) 5.81
Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ (2005) 5.65
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess (2003) 4.62
Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet (2000) 4.16
Meta-analysis and the meta-epidemiology of clinical research. BMJ (1997) 4.07
Investigating patient exclusion bias in meta-analysis. Int J Epidemiol (2004) 3.90
Quality of reporting of randomized trials as a measure of methodologic quality. JAMA (2002) 3.60
Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA (2001) 3.32
Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med (2002) 3.16
Allocation concealment and blinding: when ignorance is bliss. Med J Aust (2005) 2.85
Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ (2005) 2.80
The GATE frame: critical appraisal with pictures. Evid Based Med (2006) 1.60
Multivariable modelling for meta-epidemiological assessment of the association between trial quality and treatment effects estimated in randomized clinical trials. Stat Med (2007) 1.45
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol (2009) 17.92
Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol (2010) 17.30
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med (2011) 15.02
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA (2007) 11.87
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62
Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet (2004) 9.88
Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med (2008) 9.39
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ (2008) 8.70
Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One (2009) 8.58
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46
Developing core outcome sets for clinical trials: issues to consider. Trials (2012) 8.39
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med (2012) 8.39
Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA (2003) 8.21
Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet (2005) 7.89
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet (2007) 7.61
Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One (2009) 7.60
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
Consort 2010 statement: extension to cluster randomised trials. BMJ (2012) 7.47
Guidance for developers of health research reporting guidelines. PLoS Med (2010) 7.43
Diagnostic tests 4: likelihood ratios. BMJ (2004) 7.33
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev (2015) 7.31
Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? BMJ (2002) 7.26
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet (2009) 6.92
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ (2011) 6.89
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet (2002) 6.61
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ (2003) 6.61
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet (2005) 6.60
Epidemiology and reporting of randomised trials published in PubMed journals. Lancet (2005) 6.55
Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet (2004) 6.35